As a comparator HIV blood based self test patented by Atomo appears to have been tested in 2015&16 and approved in 2017 with funding and
influence from Gates Foundation , A 2 year clinical test period is not unusual for a medical diagnostic . IMO AXE bio chip is not in a
better position The complexity of the bio chipped and lack of any proof of concept evidence puts it in a different class to a RAT (see
generally ANN 16/4/2020 ATOMO & https://www.sofpromed.com/how-much-does-a-clinical-trial-cost )
Ann: Graphene integrated with silicon electronics, page-29
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.005(2.17%) |
Mkt cap ! $59.88M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $39.90K | 172.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 155805 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 62657 | 5 |
View Market Depth
| Last trade - 11.06am 27/06/2025 (20 minute delay) ? |
| AXE (ASX) Chart |